首页|经尿道前列腺电切术联合坦索罗辛治疗良性前列腺增生的临床疗效分析

经尿道前列腺电切术联合坦索罗辛治疗良性前列腺增生的临床疗效分析

扫码查看
目的 探讨良性前列腺增生中经尿道前列腺电切术联合坦索罗辛治疗的临床效果分析.方法 选取2020年5月—2023年5月山东省莒南县人民医院泌尿外科收治的60例良性前列腺增生患者为研究对象,采用双盲法将患者分为应用经尿道前列腺电切术治疗的对照组和应用经尿道前列腺电切术联合坦索罗辛治疗的联合组,每组30例.比较两组患者治疗效果.结果 治疗后,联合组国际前列腺症状评分和泌尿症状困扰评分均明显低于对照组,差异有统计学意义(P均<0.05).治疗后,联合组残余尿量、前列腺体积均低于对照组,差异有统计学意义(P均<0.05).联合组最大尿流率(23.54±3.24)mL/s高于对照组的(17.63±2.23)mL/s,差异有统计学意义(t=8.229,P<0.05).联合组生活质量评分高于对照组,差异有统计学意义(P<0.05).结论 良性前列腺增生患者治疗中,除应用经尿道前列腺电切术对患者的增生组织进行切除之外,联合坦索罗辛治疗可有效改善患者疾病症状,有利于提高患者控尿能力,改善患者生活质量,对于患者预后恢复具有积极意义.
Clinical Effect of Transurethral Resection of Prostate Combined with Tam-sulosin in the Treatment of Benign Prostatic Hyperplasia
Objective To investigate the clinical effect of transurethral resection of prostate combined with tamsulosin in the treatment of benign prostatic hyperplasia.Methods A total of 60 patients with benign prostatic hyperplasia ad-mitted to the Department of Urology,Junan County People's Hospital of Shandong Province from May 2020 to May 2023 were selected as the research objects.The patients were divided into the control group treated with transurethral resection of the prostate and the combined group treated with transurethral resection of the prostate combined with tamsulosin by double-blind method,with 30 cases in each group.The therapeutic effects of the two groups were com-pared.Results After treatment,the International Prostate Symptom Scores and Bother of Score in the combined group were significantly lower than those in the control group,and the differences were statistically significant(both P<0.05).After treatment,the residual urine volume and prostate volume in the combined group were lower than those in the control group,and the differences were statistically significant(both P<0.05).The maximum urinary flow rate of the combined group(23.54±3.24)mL/s was higher than that of the control group(17.63±2.23)mL/s,and the difference was statistically significant(t=8.229,P<0.05).The quality of life scores of the combined group were higher than those of the control group,and the difference was statistically significant(P<0.05).Conclusion In the treatment of patients with benign prostatic hyperplasia,in addition to the application of transurethral resection of the prostate to remove the patient's hyperplastic tissue,combined with tamsulosin treatment can effectively improve the patient's disease symp-toms,improve the patient's urinary control ability,improve the patient's quality of life,and have positive significance for the patient's prognosis recovery.

Benign prostatic hyperplasiaTransurethral resection of prostateTamsulosin

刘子明

展开 >

山东省莒南县人民医院泌尿外科,山东莒南 276600

良性前列腺增生 经尿道前列腺电切术 坦索罗辛

2024

系统医学

系统医学

ISSN:
年,卷(期):2024.9(8)